Clinico-Epidemiological Profile of Type II Diabetes Mellitus in India A Multicentric Institutional Based Survey
Pramila Kalra,Gurinder Mohan,Iadarilang Tiewsoh,Raveendra K.R,Ravi Kiran M,Sreejith. N. Kumar,Sujoy Ghosh,Mala Dharmalingam,Prasanta Kumar Bhattacharya,Akanth R,Chitra S,Kaushik Pandit,Monaliza Lyngdoh,Prabhu Subram ani,Pradip Mukhopadhyay,Richa Ghay Thaman,Manish Chandey,Ramakrishna B. S,Sivaranjani Holigi,Smitha Jain,Sundararaman R,Vedantha Srinivas J,Veena Sreejith,Jamil M.D,Shafiq Rahman,R Mercy Elizabeth,Theertha Sekhar,Sreelakshmi P R,Monika Vempadapu,Aditi Sharma,Reetu Singh,Karan Odedra
DOI: https://doi.org/10.1101/2024.11.06.24316048
2024-11-08
Abstract:Background: The epidemic of diabetes mellitus is one of the leading causes of mortality globally.
Therefore, the goal of the registry is to create a database on individuals with diabetes mellitus that may be
utilized to provide data on clinico epidemiological profile of Diabetes Mellitus in the real world.
Methods: Data for this registry is captured at seven sites across India recognized by Biotechnology Industry
Research Assistance Council (BIRAC). This is an observational multi-centric study, which registered
around 25077 Diabetic patients over a period of 3 years (December 2023.
Results: Out of 25077 patients, 12793 (51%) were male and 12284 (49%) females. There were 11443(46%)
rural patients, and 13575(54%) urban patients. Most patients registered were over 50 years.
Diabetes was seen as a burden for 46% of individuals and their families. Less than 40% of patients
exercised. Over half of the patients had a family history of diabetes. This explains the exponential rise of
diabetes mellitus over generations and the significance of preventing it.
Conclusion: This registry revealed the impact of the clinic epidemiological aspects of Diabetes Mellitus
on a larger number of samples. Future healthcare planners, researchers, and government officials will
benefit from this diabetes registry in developing primary and secondary preventive initiatives that might
minimize the rising healthcare burden of diabetes.
Endocrinology (including Diabetes Mellitus and Metabolic Disease)